Author: Ron J. Kamis
This post discussing the Patent Office’s examination policy regarding biotechnology and chemical inventions following the recent Supreme Court Myriad decision.
As many of you already know, on March 4, 2014, the United States Patent and Trademark Office (PTO) issued guidelines to […]